Medytox, a biopharmaceutical company, was Korea’s first botulinum-toxin product developer and introduced its own hyaluronic-acid filler and fat-reduction injectable.
Public$57.8M
753
ARS PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2015San Diego, CA, USest. 2015
ARS Pharmaceuticals: Innovating intranasal epinephrine sprays for allergy relief in Washington.
Unichem Laboratories is an Indian pharmaceutical company that manufactures and markets formulations and is active in active pharmaceutical ingredients.
Cuorips’ competitive position rests on a university spin-out lineage carried through a business transfer and one product franchise with regulatory approval. Cellcube, established to put Osaka University inventions into practical use, founded Cuore to commercialize human iPS cell-derived cardiomyocyte sheets. Cuorips took over that business from Cellcube and changed its corporate name from Cuore Co., Ltd. to Cuorips Co., Ltd.
Cuorips holds Japan’s conditional, time-limited manufacturing and marketing approval for Reheart, its human iPS cell-derived cardiomyocyte sheet, to treat patients with severe heart failure due to ischemic cardiomyopathy that responds inadequately to standard therapy, including drug and invasive treatment.